Several leading firms worldwide focus on the production of complex medicinal APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone. These compounds present significant hurdles in synthetic creation due to their structural intricacy. The manufacturers of these APIs often employ sophisticated methods and adhere to strict regulatory standar